Tocolytics for preterm labor: A systematic review

被引:258
作者
Gyetvai, K
Hannah, ME
Hodnett, ED
Ohlsson, A
机构
[1] Mt Sinai Hosp, Dept Paediat, Fac Nursing, Toronto, ON, Canada
[2] Univ Toronto, Ctr Res Womens Hlth, Maternal & Infant Reprod Hlth Res Unit, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0029-7844(99)00329-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the effectiveness of any tocolytic compared with a placebo or no tocolytic for preterm labor. Data Sources: We checked MEDLINE (1966-1998) and the Cochrane Controlled Trials Register for articles, using the search terms "randomized controlled trial" (RCT), "preterm labor," "tocolysis," "betamimetics," "ritodrine," "terbutaline," "hexaprenaline," "isoxuprine," "prostaglandin synthetase inhibitors," "indomethacin," "sulindac," "calcium channel blockers," "nifedipine," "oxytocin receptor blockers," "atosiban," "nitroglceride," and "magnesium sulfate." Methods of Study Selection: We included all RCTs that compared effect of a tocolytic with a placebo or no tocolytic in women in preterm labor, and reported perinatal, neonatal, or maternal outcomes. Studies were excluded if loss to follow-up exceeded 20% of those originally enrolled, or if data were not reported on a per-patient-treated basis. Eighteen of 76 articles retrieved met the inclusion criteria. Tabulation, Integration, and Results: Two authors independently reviewed the articles and abstracted the data. Discrepancies were resolved by consensus. Meta-analyses (odds ratio [OR] and 95% confidence interval [CII]) were done for each outcome for all trials and for specific types of tocolytic therapy when possible. Tocolytics decreased the risk of delivery within 7 days (OR 0.60, 95% CI 0.38, 0.95). Betamimetics, indomethacin, atosiban, and ethanol, but not magnesium sulfate, were associated with significant prolongations in pregnancy. Tocolytics were not associated with improved perinatal outcomes. Maternal side effects significantly associated with tocolytic use were palpitations, nausea, tremor, chorioamnionitis, hyperglycemia, hypokalemia, and need to discontinue treatment. Conclusion: Although tocolytics prolong pregnancy, they have not been shown to improve perinatal or neonatal outcomes and have adverse effects on women in preterm labor. (Obstet Gynecol 1999;94:869-77. (C) 1999 by The American College of Obstetricians and Gynecologists.).
引用
收藏
页码:869 / 877
页数:9
相关论文
共 79 条
[1]  
ADAM SG, 1966, AUST NZ J OBSTET GYN, V6, P294
[2]   PREVENTION OF PRETERM BIRTH - EARLY DETECTION AND AGGRESSIVE TREATMENT WITH TERBUTALINE [J].
ADKINS, RT ;
VANHOOYDONK, JE ;
BRESSMAN, PL ;
GROWDON, JH ;
BOLEN, PR ;
VARIN, JC ;
THOMPSON, BR .
SOUTHERN MEDICAL JOURNAL, 1993, 86 (02) :157-164
[3]   AMPICILLIN PROPHYLAXIS IN PRETERM PREMATURE RUPTURE OF THE MEMBRANES - A PROSPECTIVE RANDOMIZED STUDY [J].
AMON, E ;
LEWIS, SV ;
SIBAI, BM ;
VILLAR, MA ;
ARHEART, KL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 159 (03) :539-543
[4]   FAILURE TO PREVENT PRETERM LABOR AND DELIVERY IN TWIN PREGNANCY USING PROPHYLACTIC ORAL SALBUTAMOL [J].
ASHWORTH, MF ;
SPOONER, SF ;
VERKUYL, DAA ;
WATERMAN, R ;
ASHURST, HM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (10) :878-882
[5]  
BROWN SM, 1981, OBSTET GYNECOL, V57, P22
[6]  
Calder AA, 1985, PRETERM LABOUR ITS C, P209
[7]   OUTPATIENT ORAL SULINDAC TO PREVENT RECURRENCE OF PRETERM LABOR [J].
CARLAN, SJ ;
OBRIEN, WF ;
JONES, MH ;
OLEARY, TD ;
ROTH, L .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (05) :769-774
[8]  
CHRISTENSEN KK, 1980, OBSTET GYNECOL, V55, P187
[9]  
CHRISTMAS JT, 1992, OBSTET GYNECOL, V80, P759
[10]   A MULTICENTER STUDY OF PRETERM BIRTH-WEIGHT AND GESTATIONAL-AGE SPECIFIC NEONATAL-MORTALITY [J].
COPPER, RL ;
GOLDENBERG, RL ;
CREASY, RK ;
DUBARD, MB ;
DAVIS, RO ;
ENTMAN, SS ;
IAMS, JD ;
CLIVER, SP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) :78-84